CODX
$8.35
Co-Diagnostics
($.16)
(1.88%)
CODX
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  $0.21
Revenue:  $24.32 Mil
Monday
Nov 15
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CODX reports earnings?
Beat
Meet
Miss

Where is CODX's stock price going from here?
Up
Flat
Down
Stock chart of CODX
Analysts
Summary of analysts' recommendations for CODX
Score
Grade
Pivots
Resistance
$8.83
$8.70
$8.53

$8.40

Support
$8.23
$8.10
$7.93
Tweet
Growth
Description
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States.